General form of registration statement for all companies including face-amount certificate companies

Condensed Consolidated Balance Sheets

v3.7.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2017
Jun. 30, 2016
Jun. 30, 2015
Current assets:      
Cash $ 12,422 $ 23,014 $ 9,494
Accounts receivable - trade 128 484 445
Accounts receivable - unbilled 0 122 0
Work in process 60 22 0
Prepaid expenses and other current assets 374 264 182
Total current assets 12,984 23,906 10,121
Fixed assets, net of accumulated depreciation 25,794 25,574 13
Intangible assets, net of accumulated amortization 1,895 2,092 2,360
Security deposit 25 28 0
Total Assets 40,698 51,600 12,494
Current liabilities:      
Accounts payable (related party of $199 and $200 as of March 31, 2017 and June 30, 2016, respectively) 1,391 1,177 1,104
Accrued expenses (related party of $784 and $623 as of March 31, 2017 and June 30, 2016, respectively) 957 920 159
Capital lease obligation - current portion 180 170 0
Deferred revenue 93 24 0
Total Current Liabilities 2,621 2,291 1,263
Capital lease obligation - net of current portion 25,129 25,265 0
Total Liabilities 27,750 27,556 1,263
Commitments and Contingencies
iBio, Inc. Stockholders’ Equity:      
Preferred stock - $0.001 value; 1,000,000 shares authorized; 1 and 0 shares issued and outstanding as of March 31, 2017 and June 30, 2016, respectively 0 0 0
Common stock - $0.001 par value; 175,000,000 shares authorized; 89,118,510 and 89,109,410 shares issued and outstanding as of March 31, 2017 and June 30, 2016, respectively 89 89 77
Additional paid-in capital 80,680 67,468 59,006
Accumulated other comprehensive loss (29) (29) (25)
Accumulated deficit (67,794) (57,591) (47,827)
Total iBio, Inc. Stockholders’ Equity 12,946 9,937 11,231
Noncontrolling interest 2 14,107 0
Total Equity 12,948 24,044 11,231
Total Liabilities and Equity $ 40,698 $ 51,600 $ 12,494